Back
Flotek Industries 10K Form
Buy
60
FTK
Flotek Industries
Last Price:
8.16
Seasonality Move:
26.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | FTK/Flotek Industries Quarterly |
2023-11-08 | 10Q | FTK/Flotek Industries Quarterly |
2023-08-09 | 10Q | FTK/Flotek Industries Quarterly |
2023-05-11 | 10Q | FTK/Flotek Industries Quarterly |
2022-11-10 | 10Q | FTK/Flotek Industries Quarterly |
2022-08-11 | 10Q | FTK/Flotek Industries Quarterly |
Receive FTK News And Ratings
See the #1 stock for the next 7 days that we like better than FTK
FTK Financial Statistics
Sales & Book Value
Annual Sales: | $188.06M |
---|---|
Cash Flow: | $4.84M |
Price / Cash Flow: | 85.54 |
Annual Sales: | $3.66 |
Price / Book: | 2.23 |
Profitability
EPS (TTM): | 0.26000 |
---|---|
Net Income (TTM): | $8.17M |
Gross Margin: | $24.26M |
Return on Equity: | 7.85% |
Return on Assets: | 5.22% |
Flotek Industries Earnings Forecast
Key Flotek Industries Financial Ratios
- The Gross Profit Margin over the past 26 years for FTK is 12.90%.
- The Selling, General & Administrative Expenses for FTK have been equal to 14.82% of Gross Profit Margin.
- The Research & Development expenses have been 1.32% of Revenue.
- The Interest Expense is 11.56% of Operating Income.
- The Net Earning history of FTK is 13.14% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Flotek Industries Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | FTK |
CUSIP: | 343389 |
Website: | flotekind.com |
Debt
Debt-to-Equity Ratio: | 0.01 |
---|---|
Current Ratio: | 1.93 |
Quick Ratio: | 1.58 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 19 |
FTK Technical Analysis vs Fundamental Analysis
Buy
60
Flotek Industries (FTK)
is a Buy
Is Flotek Industries a Buy or a Sell?
-
Flotek Industries stock is rated a Buy
The current Flotek Industries [FTK] share price is $8.17. The Score for FTK is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.